By Mariam Sunny and Sneha S K July 1 (Reuters) - Millions of Americans are expected to gain coverage for GLP-1 drugs for ...

A new Medicare GLP-1 Bridge program offers Wegovy and Zepbound to eligible seniors for $50 a month starting July 1, slashing ...

The share of U.S. adults taking GLP-1 medications to lose weight has reached a record 11%. That's about 40 million people—as ...

Weight Watchers is changing its system because of a major Ozempic side effect. Here is what the brand is doing to keep up with the trend.

Does Medicare pay for GLP-1 drugs like Ozempic for weight loss? For years, the answer has been a hard no. But a new “Bridge” ...

GoodRx reports that Medicare's new GLP-1 Bridge program allows eligible Part D enrollees to access weight-loss medications ...

For the first time, Medicare will cover GLP-1 drugs prescribed solely for weight loss for eligible beneficiaries at a $50 ...

Millions of Medicare enrollees will gain their first-ever coverage for drugs for weight loss under a temporary pilot program ...

Seniors will need to consider whether the Medicare Bridge program is right for them, as it’s set to expire next year — and stopping the drug could have consequences.

GLP-1 weight loss drugs just got a lot cheaper for many older Americans. Starting Wednesday, the federal government is ...

Weight Watchers said Tuesday that its Med+ platform will help eligible Medicare beneficiaries access GLP-1 weight-loss drugs through the new Medicare GLP-1 Bridge Program. The program, which runs from ...

By Chris Prentice and Amina Niasse NEW YORK, July 1 (Reuters) - Millions more Americans will qualify for obesity medications ...